CLINICAL TRIALS PROFILE FOR OMNIPRED
✉ Email this page to a colleague
All Clinical Trials for OMNIPRED
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00782717 ↗ | A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients | Completed | Alcon Research | Phase 2 | 2008-11-01 | The purpose of this study is to determine whether nepafenac is safe and effective for reducing the incidence of macular edema following cataract surgery in diabetic retinopathy patients. |
| NCT02229136 ↗ | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | Active, not recruiting | Novartis Pharmaceuticals | Phase 2 | 2014-09-04 | This is a randomized Phase 2 study to evaluate two different steroid-based mouth rinses (Miracle Mouth Wash plus hydrocortisone versus prednisolone oral rinse) for the prevention or treatment of everolimus-associated stomatitis (mouth sores) in postmenopausal patients undergoing treatment with an aromatase inhibitor plus everolimus. An exploratory analysis will also evaluate patient response to next anti-cancer therapy of physician's choice following discontinuation of therapy with an aromatase inhibitor plus everolimus. |
| NCT02229136 ↗ | Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus | Active, not recruiting | US Oncology Research | Phase 2 | 2014-09-04 | This is a randomized Phase 2 study to evaluate two different steroid-based mouth rinses (Miracle Mouth Wash plus hydrocortisone versus prednisolone oral rinse) for the prevention or treatment of everolimus-associated stomatitis (mouth sores) in postmenopausal patients undergoing treatment with an aromatase inhibitor plus everolimus. An exploratory analysis will also evaluate patient response to next anti-cancer therapy of physician's choice following discontinuation of therapy with an aromatase inhibitor plus everolimus. |
| NCT02373137 ↗ | Descemet Endothelial Thickness Comparison Trial | Active, not recruiting | Stanford University | Phase 4 | 2015-01-22 | The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK. |
| NCT02373137 ↗ | Descemet Endothelial Thickness Comparison Trial | Active, not recruiting | University of California, San Francisco | Phase 4 | 2015-01-22 | The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OMNIPRED
Condition Name
Clinical Trial Locations for OMNIPRED
Trials by Country
Clinical Trial Progress for OMNIPRED
Clinical Trial Phase
Clinical Trial Sponsors for OMNIPRED
Sponsor Name
